FDA Inspection 1026727 — Ingenus Pharmaceuticals NJ, LLC.

Ingenus Pharmaceuticals NJ, LLC. — FEI 2246963

The FDA completed an inspection of Ingenus Pharmaceuticals NJ, LLC. on September 27, 2017 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fairfield, NJ (United States)